Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Tax harvesting to lower capital gains automates selling decisions to reduce taxes while maintaining portfolio goals.
25,625 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Global X's RYLD, a Russell 2000 covered-call ETF, underperforms uncapped peers this year as small-cap volatility ease...
Moderna and Ross Stores surged midweek on distinct catalysts: a patent settlement clearing a key overhang for Moderna...
When a blue-chip stock posts a stunning earnings beat, investors flock to understand what comes next. This guide brea...
The AI hype is undeniable, but investors want answers: is this a bubble about burst just or the start of a longer asc...
Investors chase stocks with accelerating growth and clear catalysts. This guide explains how to identify a supercharg...
Long-term investors chase multibagger dreams. This article explores a high-potential biotech setup with 26 late-stage...
In this analysis, we unpack what Andy Jassy's recent remarks mean for Amazon stock and AWS growth. Learn actionable s...
Lululemon has faced headwinds after a peak stretch. This article outlines whether lululemon stock recover? is feasibl...
A rising wave of data centers and AI workloads is straining power grids. Learn how a strategic nuclear stock could ri...
Praxis (Prax) 2026 earnings signals a path from solid growth to stronger profitability. This analysis breaks down the...
Intel overcame a tough 12 months to deliver a striking rebound. Analysts say the AI-led strategy and foundry expansio...